Significance of Metabolic Tumor Volume and Total Lesion Glycolysis Measured Using 18F-FDG PET/CT in Locally Advanced and Metastatic Gallbladder Carcinoma-Reference-Cited by-同舟云学术

Significance of Metabolic Tumor Volume and Total Lesion Glycolysis Measured Using 18F-FDG PET/CT in Locally Advanced and Metastatic Gallbladder Carcinoma

Published:2019 Issue:7 Volume:60 Page:604
ISSN:0513-5796
Container-title:Yonsei Medical Journal
language:en
Short-container-title:Yonsei Med J

Author:

Chun You Jin¹^ORCID,Jeung Hei-Cheul²^ORCID,Park Hyung Soon³^ORCID,Park Ji Soo⁴^ORCID,Rha Sun Young¹^ORCID,Choi Hye Jin¹^ORCID,Lee Jae-Hoon⁵^ORCID,Jeon Tae Joo⁵^ORCID

Affiliation:

1. Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.

2. Division of Medical Oncology, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.

3. Division of Medical Oncology, Department of Internal Medicine, St. Vincent's Hospital, The Catholic University of Korea, Suwon, Korea.

4. Cancer Prevention Center, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.

5. Department of Nuclear Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.

Publisher

Yonsei University College of Medicine

Subject

General Medicine

Link

https://synapse.koreamed.org/pdf/10.3349/ymj.2019.60.7.604

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Automatic detection and segmentation of lesions in 18F-FDG PET/CT imaging of patients with Hodgkin lymphoma using 3D dense U-Net;Nuclear Medicine Communications;2024-09-03

2. Gallbladder’s Adenocarcinoma With Enteroblastic Differentiation Revealed by 18F-FDG PET/CT;Clinical Nuclear Medicine;2024-01-16

3. Metabolic parameters of pretreatment 2-[18F]fluoro-D-glucose positron emission tomography for prognosis in patients with gallbladder adenocarcinoma: a cohort study;Quantitative Imaging in Medicine and Surgery;2024-01

4. Molecular Response Assessment with Immune Adaptive PERCIST in Lung Cancer Patients Treated with Nivolumab: Is It Better Than iRECIST?;World Journal of Nuclear Medicine;2022-03

5. Molecular response assessment with immune adaptive positron emission tomography response criteria in solid tumors in lung cancer patients treated with nivolumab: Is it better than immune response evaluation criteria in solid tumors?;World Journal of Nuclear Medicine;2022